Skip to main content

The Globe and Mail

Marijuana producers lobby Ottawa ahead of legalization legislation

Medical marijuana is ready for shipping is pictured January 21, 2016 at Tweed Inc., one of the marijuana producers lobbying the federal government.

Dave Chan/The Globe and Mail

Several licensed marijuana producers have penned a letter to Ottawa, urging the federal government to allow them to brand their products and provide medical cannabis on a tax-free basis.

The seven producers – Tilray, Tweed, Mettrum, CannTrust, Green Organic Dutchman Holdings, RedeCan Pharm and Delta 9 Bio-Tech – are lobbying the government ahead of the week of April 10, when legislation legalizing recreational use of the drug is expected to be introduced.

A federal task force has recommended requiring plain packaging for cannabis and advertising restrictions similar to those placed on the tobacco industry.

Story continues below advertisement

But in their letter, the licensed producers argue that preventing them from branding their products will make it tougher for them to compete with black market operations such as illegal dispensaries.

"Brands allow professional companies to separate themselves from less scrupulous competitors," says Brendan Kennedy, president of B.C.-based marijuana producer Tilray.

Some health advocates have argued that restricting branding and advertising is necessary in order to ensure that users are aware of possible health risks associated with the substance.

Another concern is that cannabis producers could use advertising to compel widespread usage of the drug, similar to what occurred with tobacco and alcohol in the past.

But the licensed producers say they aren't looking to lure people into consuming marijuana. Instead, they wish to use branding and in-store advertising to educate users about various strains and their impacts, according to the letter.

"No one in this industry is looking to repeat the same mistakes as tobacco or alcohol," says Kennedy. "No one wants to see a Joe Camel of this industry."

Cannabis producers also take issue with the tax force's recommendation that medical and recreational cannabis be taxed the same amount.

Story continues below advertisement

This would "unduly burden" medical cannabis patients, according to the companies, who argue that medical cannabis should be sold tax free.

"Other pharmaceutical products aren't taxed," says Kennedy.

Report an error
About the Author
Business Reporter

Alexandra Posadzki joined the ROB in August 2017, after spending nearly three years covering banking and real estate, among other topics, for the Canadian Press newswire. More

Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨